INS and diabetes mellitus: Prabakaran et al[91] found that oral administration of esculetin (10–40 mg/kg) significantly reduced blood glucose levels and increased plasma insulin levels in diabetic rats, and ameliorated diabetes-induced tissue damage in the liver and kidney by attenuating hyperglycemia-mediated oxidative stress.